about
Increase in cerebellar volume in Cavalier King Charles Spaniels with Chiari-like malformation and its role in the development of syringomyeliaChanges over time in craniocerebral morphology and syringomyelia in cavalier King Charles spaniels with Chiari-like malformation.How long and low can you go? Effect of conformation on the risk of thoracolumbar intervertebral disc extrusion in domestic dogsInternational Veterinary Epilepsy Task Force consensus reports on epilepsy definition, classification and terminology, affected dog breeds, diagnosis, treatment, outcome measures of therapeutic trials, neuroimaging and neuropathology in companion anA randomised trial of a medium-chain TAG diet as treatment for dogs with idiopathic epilepsy.Imaging the cranial nerves.Neuromuscular disorders in the cat: clinical approach to weakness.Current insights and controversies in the pathogenesis and diagnosis of disc-associated cervical spondylomyelopathy in dogs.Clinical presentation, diagnostic findings and outcome in dogs diagnosed withpresumptive spinal-only meningoen-cephalomyelitis of unknown origin.Survey of veterinary clients' perceptions of informed consent at a referral hospital.Dogs attending primary-care practice in England with clinical signs suggestive of Chiari-like malformation/syringomyelia.Clinical reasoning in canine spinal disease: what combination of clinical information is useful?Clinical presentation, diagnostic findings and long-term survival in large breed dogs with meningoencephalitis of unknown aetiology.Porencephaly and hydranencephaly in six dogs.Questionnaire-based behaviour analysis of Cavalier King Charles spaniels with neuropathic pain due to Chiari-like malformation and syringomyelia.Clinical outcome in 19 cats with clinical and magnetic resonance imaging diagnosis of ischaemic myelopathy (2000-2011).Comparison of gabapentin versus topiramate on clinically affected dogs with Chiari-like malformation and syringomyelia.Neuronal expression of the drug efflux transporter P-glycoprotein in the rat hippocampus after limbic seizures.Multidrug resistance in epilepsy: rats with drug-resistant seizures exhibit enhanced brain expression of P-glycoprotein compared with rats with drug-responsive seizures.The association between Chiari-like malformation, ventriculomegaly and seizures in cavalier King Charles spaniels.Prevalence and risk factors for canine epilepsy of unknown origin in the UK.Imaging diagnosis-malignant peripheral nerve sheath tumor presenting as an intra-axial brain mass in a young dog.Relationship of brain parenchyma within the caudal cranial fossa and ventricle size to syringomyelia in cavalier King Charles spaniels.Quality-of-life aspects in idiopathic epilepsy in dogs.Assessment of mitral regurgitation in dogs: comparison of results of echocardiography with magnetic resonance imaging.Comparing the effects of first-line antiepileptic drugs on the gait of dogs with idiopathic epilepsy.Cervical intervertebral foraminal disc extrusion in dogs: clinical presentation, MRI characteristics and outcome after medical management.Owner perception of focal seizures in canine epilepsy.Responses to successive anti-epileptic drugs in canine idiopathic epilepsy.Distinct cerebellar foliation anomalies in a CHD7 haploinsufficient mouse model of CHARGE syndrome.An exploratory study using a statistical approach as a platform for clinical reasoning in canine epilepsy.Antiepileptic drug-resistant rats differ from drug-responsive rats in hippocampal neurodegeneration and GABA(A) receptor ligand binding in a model of temporal lobe epilepsy.Brain abscess in seven cats due to a bite wound: MRI findings, surgical management and outcome.Imaging diagnosis--spinal cord hemangioma in two dogs.Cervical vertebral stenosis associated with a vertebral arch anomaly in the Basset Hound.Striking differences in individual anticonvulsant response to phenobarbital in rats with spontaneous seizures after status epilepticus.Effect of prolonged status epilepticus as a result of intoxication on epileptogenesis in a UK canine population.Significance of surface epithelial cells in canine cerebrospinal fluid and relationship to central nervous system disease.Metabolic perturbations associated with the consumption of a ketogenic medium-chain TAG diet in dogs with idiopathic epilepsyMiddle ear effusions in dogs: an incidental finding?
P50
Q28730667-4E5747FE-BEA2-478F-BAA5-D58B4198C3ABQ34471015-0B312BFC-92FF-4F2B-B6B5-A066D0BB0BE3Q34874187-4F781791-1AEF-4DBD-BAA2-48EE765BC083Q35758257-A0187EBE-15E7-4834-BC6B-1B0C7A89A991Q36255606-12BCAB64-C014-4B81-A6BE-AB4FC1400BD2Q37851569-0F1A322D-7AFA-4411-A6ED-B35D25615FB8Q37953712-D88E6B94-4D0D-482D-9307-9EA75D3022B0Q38062518-C61C7638-DBE5-48EB-BEEE-89783CA7A52EQ38925110-02CE2D09-AC30-400A-9D4D-BFC0ACF1B463Q39293840-B2462AB7-374C-4D21-AB78-D9D225692563Q39480573-1D74B740-8290-4460-8DAA-DC61CDF6DD3DQ40711335-16AE6D60-CB8E-42CE-841F-B291D57A04A5Q40760471-6D255871-3B16-46B5-AFDC-1E38F4C392FFQ41934544-B36566BA-2C92-4900-A05F-8AF02B75AB1BQ43854316-71454D34-0B40-43D2-B66E-15CBD12B08D6Q44339924-D4A0FCD3-61C0-45C8-92A4-13C09CD8ED92Q44456466-D3C8702D-4AB7-4EEF-960E-E8F4E15AC93CQ44714742-A4E05597-EB5F-434A-9E1E-1A02D7984B5BQ45269834-CAA18370-FEC7-4F09-BDE6-15BB9F36C138Q45338050-EF40A6D4-2185-4D4B-97E0-9ED1B1949B63Q45366949-F111015A-0AC4-4CC3-AF2C-D682969BB9FCQ46959771-755A0DE5-8DD3-42D0-B92F-4DCD2F335A67Q47428956-BB911B83-1C3E-4CD1-BBE7-671AA9B21DD4Q47718380-97F0DC59-E4CC-4C6B-AA65-7D3FF2E7BA09Q48118960-520DAA69-AD1B-4A37-BF32-F692A6153CEBQ48199908-9D9D5A44-BD88-4D33-9DE0-D319B5BE2961Q48218782-94BAF1F2-0B04-4353-A80C-292EBC298E5BQ48219459-531B0562-0669-4E5A-B673-1A5ED1D6FF4AQ48237754-D0D8188D-D870-49AF-912E-9548AF8C0519Q48248088-3E12272F-4B9E-4E2D-BF18-D9E5F169CA5EQ48527368-D50AC8AB-01E9-4FE2-A6A0-21B1E27AC1E7Q48713658-BB54C343-E468-4662-923B-86228F4BA835Q48930412-97F6511A-3B23-4BAC-985E-EB12D50B4F89Q50616053-CF397064-B82C-403C-8F62-5274C1E77FDAQ51310781-B1F34F50-5C99-486A-AD72-1A4D5CC305B5Q51574148-929A949E-E378-449F-A812-6754D0CA06F7Q52726150-2D308535-1009-4D3A-8D56-B140315CD34AQ53305073-2BDCCC73-A9CF-499E-9615-8BEDBA44153BQ57162761-E28D5555-D82F-4112-ACCE-4CF1A49567BEQ57644704-61AAAD9A-1EAA-4B18-AEC5-196A26F85E05
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Holger A Volk
@ast
Holger A Volk
@en
Holger A Volk
@es
Holger A Volk
@nl
type
label
Holger A Volk
@ast
Holger A Volk
@en
Holger A Volk
@es
Holger A Volk
@nl
prefLabel
Holger A Volk
@ast
Holger A Volk
@en
Holger A Volk
@es
Holger A Volk
@nl
P106
P1153
7202998990
P31
P496
0000-0002-7312-638X